Green Healthcare Sol'ns v. Med. Cannabis Comm'n

CourtCourt of Special Appeals of Maryland
DecidedApril 28, 2022
Docket0766/21
StatusPublished

This text of Green Healthcare Sol'ns v. Med. Cannabis Comm'n (Green Healthcare Sol'ns v. Med. Cannabis Comm'n) is published on Counsel Stack Legal Research, covering Court of Special Appeals of Maryland primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Green Healthcare Sol'ns v. Med. Cannabis Comm'n, (Md. Ct. App. 2022).

Opinion

Green Healthcare Solutions, LLC v. Natalie M. LaPrade Maryland Medical Cannabis Commission, No. 766, September Term, 2021. Opinion by Graeff, J.

ADMINISTRATIVE LAW — EXHAUSTION OF REMEDIES — ADMINISTRATIVE MANDAMUS

The General Assembly gave the Medical Cannabis Commission broad authority to regulate the medical cannabis industry. Although there is no explicit statutory language providing an administrative remedy for high-ranking applicants to challenge the denial of a grower or processor license, the broad language of the statute gives the Commission implied authority to set up an administrative review remedy. If the Commission had adopted regulations to provide for such a remedy, it could have created a requirement that the administrative remedy be exhausted prior to instituting judicial action. The Commission did not, however, enact a regulation providing for an administrative remedy for unsuccessful applicants for a processor license. Where no administrative review remedy was authorized by statute or an administrative scheme, there was no exhaustion requirement. The circuit court erred in finding that GHS’s petition should be dismissed for failure to exhaust administrative remedies.

Administrative mandamus involves judicial review of a quasi-judicial order or action of an administrative agency where such review is not expressly authorized by law. In concluding that the request for administrative mandamus failed to state a claim upon which relief could be granted, the circuit court improperly focused on the availability of administrative review instead of whether judicial review of the Commission’s actions was expressly authorized by law. Circuit Court for Anne Arundel County Case No. C-02-CV-21-000328

REPORTED

IN THE COURT OF SPECIAL APPEALS

OF MARYLAND

No. 766

September Term, 2021

______________________________________

GREEN HEALTHCARE SOLUTIONS, LLC

v.

NATALIE M. LAPRADE MARYLAND MEDICAL CANNABIS COMMISSION

Graeff, Nazarian, Eyler, James R. (Senior Judge, Specially Assigned),

JJ. ______________________________________

Opinion by Graeff, J. ______________________________________

Filed: April 28, 2022

Pursuant to Maryland Uniform Electronic Legal Materials Act (§§ 10-1601 et seq. of the State Government Article) this document is authentic. *Ripken, Laura, J., did not participate in the 2022-04-28 09:22-04:00 Court’s decision to designate this opinion for publication pursuant to Md. Rule 8-605.1. Suzanne C. Johnson, Clerk Green Healthcare Solutions, LLC (“GHS”), appellant, appeals from the order issued

by the Circuit Court for Anne Arundel County dismissing its Petition for a Writ of

Mandamus, or in the alternative, for a Declaratory Judgment. The petition requested that

the court order that the Natalie M. LaPrade Medical Cannabis Commission (the

“Commission”), appellee, award stage-one preapproval of GHS’s application for a medical

cannabis processor license.

On appeal, GHS presents the following questions for this Court’s review, which we

have rephrased slightly, as follows:

1. Did the circuit court err in granting the Commission’s motion to dismiss GHS’s petition on the ground that it failed to exhaust administrative remedies?

2. Did the circuit court err in dismissing GHS’s petition for administrative mandamus on the ground that there was an administrative remedy available to GHS?

For the reasons set forth below, we shall vacate the judgment of the circuit court.

FACTUAL AND PROCEDURAL BACKGROUND1

I.

Parties and the Application Process

GHS is a limited liability company with a principal place of business in Greensboro,

Maryland. The company is led by an African-American female, Chief Executive Officer

Celine Krishack. GHS submitted an application with the Commission for a medical

cannabis processor license in 2019.

1 Because this appeal is from a motion to dismiss, the facts are taken from the pleadings. The Commission is an independent commission that functions within the Maryland

Department of Health, and its purpose is to “develop policies, procedures, guidelines, and

regulations to implement programs to make medical cannabis available to qualifying

patients in a safe and effective manner.” Md. Code Ann., Health-Gen. Art. (“HG”) § 13-

3302(a)–(c) (2019 Repl. Vol.). The statute authorizes the Commission, in addition to other

things, to issue licenses to growers, processors, and dispensaries of medical cannabis in

Maryland. HG §§ 13-3306, 13-3307, 13-3309.

Subject to exceptions, the statute provides for no more than 28 licensed processors.

HG § 13-3309(c)(1)(i).2 The Commission has authority to “establish an application review

process for granting processor licenses in which applications are reviewed, evaluated, and

ranked based on criteria established by the Commission.” HG § 13-3309(c)(3). In issuing

processor licenses, the Commission shall “actively seek to achieve racial, ethnic, gender,

and geographic diversity” and encourage minority or women-owned business entities to

apply for licensure as processors. HG § 13-3309(c)(4)(i)(1)–(2).

The Maryland Code of Regulations (“COMAR”) sets forth the application

requirements for a medical cannabis processor license. COMAR 10.62.19.02. It also sets

forth the weighted criteria on which the applications would be ranked for a preapproval

license. COMAR 10.62.19.04I. Consideration was given, up to five percent, for applicants

who had a certain percentage of ownership interest held by those who qualified as a

2 The Commission stated in its brief in this Court, and in its argument to the circuit court, that some licenses were awarded prior to GHS’s 2019 application, and up to ten medical cannabis processor licenses were available in the 2019 application round. 2 Disadvantaged Equity Applicant (“DEA”), i.e., an applicant who is a member of a minority

group or a woman and met certain requirements, including having a personal net worth that

does not exceed $1,713,333. COMAR 10.62.19.04I(6), 10.62.01.B(12); see also Maryland

Medical Cannabis Commission, Grower and Processor License Applications, Guidance for

the Diversity and Socioeconomic Equity Questions. Each processor license applicant bears

the burden of proving their qualifications. COMAR 10.62.19.04A.

GHS’s 2019 application identified Mrs. Krishack as a DEA. In July 2019, the

Commission staff conducted an initial review of the applications to determine whether they

met the minimum requirements for evaluation. The applications were then transferred to

Morgan State University (“MSU”) as an independent evaluator to analyze, score, and rank

applicants based on the qualifications represented in their applications. The MSU

evaluators were not responsible for reviewing and scoring sections of the applications

related to DEA status, which were reviewed by the Commission staff. The scores and

ranking submitted by the MSU evaluators were compiled with the sections scored by the

Commission staff, and an adjusted ranking of applicants was produced.

On September 18, 2019, the Commission voted to adopt the rankings for the purpose

of investigating the highest-ranking applicants. This next-level investigation was designed

to ascertain the veracity of the responses and information provided in the applications, i.e.,

to investigate the ownership interests of members who represented themselves as a DEA.

On September 21, 2019, the Commission notified GHS that it was among the highest-

ranking applicants for a processor license.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Daurelle v. Traders Federal Savings & Loan Ass'n
104 S.E.2d 320 (West Virginia Supreme Court, 1958)
City of Annapolis v. Bowen
920 A.2d 54 (Court of Special Appeals of Maryland, 2007)
Maryland Port Administration v. C. J. Langenfelder & Son, Inc.
438 A.2d 1374 (Court of Special Appeals of Maryland, 1982)
Md.-Nat'l Cap. P. & P. v. Wash. Nat'l Arena
386 A.2d 1216 (Court of Appeals of Maryland, 1978)
Goodwich v. Nolan
680 A.2d 1040 (Court of Appeals of Maryland, 1996)
Zappone v. Liberty Life Insurance
706 A.2d 1060 (Court of Appeals of Maryland, 1998)
City of Bowie v. MIE, Properties, Inc.
922 A.2d 509 (Court of Appeals of Maryland, 2007)
Arroyo v. Board of Education
851 A.2d 576 (Court of Appeals of Maryland, 2004)
Gazunis v. Foster
929 A.2d 531 (Court of Appeals of Maryland, 2007)
Soley v. State Commission on Human Relations
356 A.2d 254 (Court of Appeals of Maryland, 1976)
O'Brien v. Board of License Commissioners
23 A.3d 323 (Court of Special Appeals of Maryland, 2011)
Bowen v. City of Annapolis
937 A.2d 242 (Court of Appeals of Maryland, 2007)
Theresa L. Weimer v. Thomas Sanders, etc.
752 S.E.2d 398 (West Virginia Supreme Court, 2013)
Falls Road Community Ass'n v. Baltimore County
85 A.3d 185 (Court of Appeals of Maryland, 2014)
Dugan v. Prince George's County
88 A.3d 896 (Court of Special Appeals of Maryland, 2014)
United Insurance Co. of America v. Maryland Insurance Administration
144 A.3d 1230 (Court of Appeals of Maryland, 2016)
Lamson v. Montgomery Cnty.
190 A.3d 316 (Court of Appeals of Maryland, 2018)
Chavis v. Blibaum & Assoc. Moore v. Peak Mgmt.
264 A.3d 1254 (Court of Appeals of Maryland, 2021)
Mayor & City Cnc. of Balt. v. ProVen Mgmt.
472 Md. 642 (Court of Appeals of Maryland, 2021)
Stepney, LLC v. Town of Fairfield
821 A.2d 725 (Supreme Court of Connecticut, 2003)

Cite This Page — Counsel Stack

Bluebook (online)
Green Healthcare Sol'ns v. Med. Cannabis Comm'n, Counsel Stack Legal Research, https://law.counselstack.com/opinion/green-healthcare-solns-v-med-cannabis-commn-mdctspecapp-2022.